ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ATNM Actinium Pharmaceuticals Inc

6,80
0,24 (3,66%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Actinium Pharmaceuticals Inc ATNM AMEX Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,24 3,66% 6,80 19:56:02
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,58 6,485 6,92 6,87 6,56
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/04/202409:00PRNUSActinium Highlights Ability of Iomab-B to Overcome High-Risk..
01/04/202409:00PRNUSActinium Announces Iomab-B Phase 3 SIERRA Trial Results..
26/03/202408:18PRNUSActinium Announces Clinical Trial to Study Iomab-ACT..
11/03/202408:30PRNUSActinium Pharmaceuticals Launches Actinium-225 Focused..
26/02/202409:30PRNUSActinium Announces Iomab-B Markedly Increases Long Term..
23/02/202409:30PRNUSActinium Highlights Improved Survival with Iomab-B in TP53..
02/01/202409:30PRNUSActinium Announces Acceptance of Five Abstracts for..
11/12/202310:15PRNUSActinium Announces Iomab-B Produces High Response Rates and..
11/12/202309:45PRNUSActinium's Four Presentations at ASH Highlight the Positive..
08/12/202310:00PRNUSActinium to Highlight Broad Potential of Targeted..
06/11/202309:30PRNUSActinium Presents Preclinical Data at SITC Demonstrating..
02/11/202317:15PRNUSActinium Pharmaceuticals to Attend Bio-Europe Munich 2023
02/11/202310:05PRNUSActinium Announces Oral Presentation at ASH Annual Meeting..
04/10/202308:30PRNUSActinium Announces NIH Grant Extension to Advance Clinical..
27/09/202310:05PRNUSActinium Pharma Highlights Abstract Accepted for Poster..
07/09/202309:40PRNUSActinium Pharma Presents Survival Data from Extended..
31/08/202308:00PRNUSActinium Pharma Highlights Three Abstracts Accepted for..
21/08/202308:00PRNUSActinium Pharma Highlights Abstracts Accepted for Oral and..
24/07/202308:00PRNUSActinium Pharma to Present at the 2nd Annual Targeted..
26/06/202308:00PRNUSSNMMI 2023 Annual Meeting Abstract of the Year Awarded to..
23/06/202309:00PRNUSActinium Pharma Highlights Six Abstracts Accepted for Oral..
16/06/202308:00PRNUSActinium Pharma to Present at the Maxim Healthcare Virtual..
14/06/202308:00PRNUSActinium Pharma to Present at the TD Cowen..
12/06/202308:00PRNUSActinium Announces Positive Pivotal Phase 3 SIERRA Trial..
07/06/202308:00PRNUSActinium Pharma Set to Join Russell 2000® and Russell 3000®..
22/05/202308:00PRNUSActinium Pharma Announces Six Abstracts Accepted for Oral..
11/05/202312:18PRNUSActinium Pharma Announces Iomab-B SIERRA Trial Results..
10/05/202308:00PRNUSActinium Pharma to Present at Guggenheim Healthcare Talks..
28/04/202309:00PRNUSActinium Highlights Successful Administration of Targeted..

Seu Histórico Recente

Delayed Upgrade Clock